FDA-cleared profile

Viz Subdural+, Viz SUBDURAL PLUS

Viz.ai, Inc. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: Viz Subdural+ labels, visualizes, and quantifies subdural collections from single-time-point non-contrast head CT, reporting collection grayscale value, total volume, widest width, and midline shift as annotated DICOM images for physician review with original CT.

Clinical role
Segmentation, measurement, and visualization support
Images and patients
CT/CTA · Brain
Key limitation
Keep in mind: Physicians must review the original images and full patient context; the output is assistive measurement/visualization and not a substitute for clinical interpretation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Viz Subdural+ labels, visualizes, and quantifies subdural collections from single-time-point non-contrast head CT, reporting collection grayscale value, total volume, widest width, and midline shift as annotated DICOM images for physician review with original CT.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Brain Input: Single-time-point non-contrast head CT in DICOM format; the device analyzes subdural-space collections and does not replace review of the original CT.
  • Who uses it?Intended users: Trained physicians interpreting head CT, including radiologists and other qualified clinicians
  • What does the software produce?Output: Annotated DICOM images and measurements for collection grayscale value, total volume, widest width, and midline shift; overlay opacity corresponds to the grayscale value in the native CT.
  • What is its most important limitation?Key limitation: Physicians must review the original images and full patient context; the output is assistive measurement/visualization and not a substitute for clinical interpretation.

Clinical takeaway. Clinical role: Viz Subdural+ labels, visualizes, and quantifies subdural collections from single-time-point non-contrast head CT, reporting collection grayscale value, total volume, widest width, and midline shift as annotated DICOM images for physician review with original CT.

Evidence takeaway. Evidence from the reviewed source record: Retrospective validation compared measurements with trained neuroradiologist reference values using 203 cases for volume/thickness and 151 cases for midline shift from two clinical sites.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Viz Subdural+ labels, visualizes, and quantifies subdural collections from single-time-point non-contrast head CT, reporting collection grayscale value, total volume, widest width, and midline shift as annotated DICOM images for physician review with original CT.
  • Exact FDA submission
  • Checked 2026-09-06
Workflow role
Segmentation, measurement, and visualization support
  • Exact FDA submission
  • Checked 2026-09-06
Required input
Single-time-point non-contrast head CT in DICOM format; the device analyzes subdural-space collections and does not replace review of the original CT.
  • Exact FDA submission
  • Checked 2026-09-06
Output and clinician action
Annotated DICOM images and measurements for collection grayscale value, total volume, widest width, and midline shift; overlay opacity corresponds to the grayscale value in the native CT.
  • Exact FDA submission
  • Checked 2026-09-06
Care setting
Adult head-CT interpretation and acute neuroimaging workflow
  • Exact FDA submission
  • Checked 2026-09-06
Intended users
Trained physicians interpreting head CT, including radiologists and other qualified clinicians
  • Exact FDA submission
  • Checked 2026-09-06
Limitations
Physicians must review the original images and full patient context; the output is assistive measurement/visualization and not a substitute for clinical interpretation.
  • Exact FDA submission
  • Checked 2026-09-06
Evidence summary
Retrospective validation compared measurements with trained neuroradiologist reference values using 203 cases for volume/thickness and 151 cases for midline shift from two clinical sites.
  • Exact FDA submission
  • Checked 2026-09-06

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Retrospective validation compared measurements with trained neuroradiologist reference values using 203 cases for volume/thickness and 151 cases for midline shift from two clinical sites.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Viz Subdural+ measurement validation

  • DesignRetrospective validation against trained neuroradiologist reference measurements
  • Population203 head-CT cases for collection volume and widest thickness; 151 cases for midline shift, from two clinical sites
  • Scopeexact submission
  • Tested versionViz Subdural+ submitted in K250354; build not stated
  • Samplen=203
  • Sites2
  • IndependenceIndependence not established

K250354

The FDA tables report mean absolute error and overlap statistics; unit labels were not normalized here where the extracted table did not expose them consistently.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Single-time-point non-contrast head CT in DICOM format; the device analyzes subdural-space collections and does not replace review of the original CT.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-06 · FDA 510(k) K250354: Viz Subdural+

  2. Routing

    Source context, not route validation: The submission describes DICOM input and annotated DICOM image output for review; specific PACS/workstation compatibility and routing were not established.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-06 · FDA 510(k) K250354: Viz Subdural+

  3. AI processing

    Source context, not route validation: The exact FDA package describes Viz Subdural+ as hosted on Viz.ai’s Backend Server, which receives NCCT images automatically forwarded from the healthcare facility after acquisition at the CT scanner. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Images are automatically forwarded from the Healthcare Facility and sent to Viz.ai’s Backend Server after acquisition at the CT scanner." … "Viz Subdural+ is hosted on Viz.ai’s Backend Server and automatically analyzes applicable NCCT scans". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA 510(k) K250354: Viz Subdural+

  4. Returned objects

    Source context, not route validation: Annotated DICOM images and measurements for collection grayscale value, total volume, widest width, and midline shift; overlay opacity corresponds to the grayscale value in the native CT.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-06 · FDA 510(k) K250354: Viz Subdural+

  5. Viewer/worklist/report

    Unresolved route: Annotated DICOM images and measurements for collection grayscale value, total volume, widest width, and midline shift; overlay opacity corresponds to the grayscale value in the native CT.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-06 · FDA 510(k) K250354: Viz Subdural+

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes Viz Subdural+ as hosted on Viz.ai’s Backend Server, which receives NCCT images automatically forwarded from the healthcare facility after acquisition at the CT scanner. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Images are automatically forwarded from the Healthcare Facility and sent to Viz.ai’s Backend Server after acquisition at the CT scanner." … "Viz Subdural+ is hosted on Viz.ai’s Backend Server and automatically analyzes applicable NCCT scans". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The submission describes DICOM input and annotated DICOM image output for review; specific PACS/workstation compatibility and routing were not established.
  • Exact FDA submission
  • Checked 2026-09-06
Security
Viz.ai's own news releases say the Viz.ai One platform completed a SOC 2 Type II + HIPAA audit (announced 2024-02-26) and received ISO 27001:2022 plus six other ISO certificates (announced 2024-07-10). These are vendor announcements; the report and certificates were not read, and certificate dates may have lapsed or renewed since.
  • Vendor-wide
  • Checked 2026-10-25

Vendor-wide statement, not an independent attestation. It does not establish certificate or report scope for this exact release, expiry, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.

Monitoring
Viz.ai's trust center states that its assurance program includes continuously monitored controls, SOC 2 Type II coverage that includes the availability criterion for Viz.ai production systems and supporting infrastructure, ISO 22301 business continuity certification to ensure uninterrupted clinical workflows, and ISO 27035 incident management certification.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statements, not attestations. Certificates and audit reports were not read; the trust center names Viz.ai generally and does not scope these commitments to any specific product release; exact-release scope is not established.

Annotated DICOM measurement output

The exact submission describes DICOM head-CT input and annotated DICOM images with subdural collection volume, widest width, midline shift, and grayscale-linked overlays.

exact submission · checked 2026-09-06

Viz Subdural family care coordination

Viz's official Subdural page describes automated acute/chronic subdural detection, care-team coordination, and a secure cloud-native workflow; those current family claims are not assumed for the exact K250354 measurement build.

product family · checked 2026-09-07
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K250354
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Anatomy
Brain
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-06-10
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-07Last searched
23Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

No stored PubMed or ClinicalTrials.gov candidate identifiers for this submission in the 2026-09-01 snapshot; exact-submission recall candidate review was also zero. This metadata screen is not a full paper review. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor press release, literature index, trial registry, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-07 - Exact FDA submission

    No public amount, range, currency, geography, or contract term was established.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Viz.ai Subdural reimbursement NTAP CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. Viz.ai's 2020-09-03 release announces an NTAP for its LVO stroke software; it does not name this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-07 - Exact FDA submission

    Current onboarding, competency, and support commitments were not established.

11 sources - 3 history items

Source ledger

  1. FDA 510(k) K250354: Viz Subdural+

    U.S. Food and Drug Administration - Published 2025-06-10 - Accessed 2026-09-06

    Scope: identity, purpose, clinicalUse, modality, anatomy, input, output, limitations, integration, deployment, evidenceSummary, evidenceStudies

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Viz Subdural+, Viz SUBDURAL PLUS model card (K250354)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Viz.ai receives FDA clearance for subdural measurements

    Viz.ai - Published 2025-06-12 - Accessed 2026-09-07

    Scope: exactProductIdentity, productCapabilities, implementationCapabilities

  8. Viz Subdural official product page

    Viz.ai - Accessed 2026-09-07

    Scope: productFamilyWorkflow, implementationCapabilities

  9. Viz.ai Announces Completion of SOC 2 Type II + HIPAA Audits

    Viz.ai, Inc. - Published 2024-02-26 - Accessed 2026-10-25

    Scope: security

  10. Viz.ai Strengthens Information Security with ISO Certification

    Viz.ai, Inc. - Published 2024-07-10 - Accessed 2026-10-25

    Scope: security

  11. Viz.ai: Trust Center

    Viz.ai - Accessed 2026-10-27

    Scope: security

Research history

  1. K250354 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260406

Brainomix 360 Hyperdensity

Brainomix Limited

Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.

Modality
CT/CTA
Anatomy
Brain
Decision
2026-06-12
FDA-cleared K251151

Rapid CTA 360

iSchemaView

Authorized purpose: Rapid CTA 360 analyzes adult head CTA DICOM images to flag suspected large- and medium-vessel occlusion in specified intracranial and vertebral segments and notify trained clinicians for workflow triage; notifications are informational and not diagnostic.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-07-16
FDA-cleared K243378

Rapid MLS

iSchemaview Inc.

Authorized purpose: Brain midline-shift measurement on adult non-contrast CT

Modality
CT/CTA
Anatomy
Brain
Decision
2025-05-28
FDA-cleared K243294

Brainomix 360 e-ASPECTS

Brainomix Limited

Authorized purpose: Brainomix 360 e-ASPECTS registers adult non-contrast brain CT, segments ASPECTS regions, and provides an editable ASPECTS score with highlighted regions and voxel contribution views to assist trained clinicians evaluating suspected ischemic stroke within 24 hours of last known well.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-02-14

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history